Neurocrine Biosciences, Inc. (BVMF:N1BI34)
Brazil flag Brazil · Delayed Price · Currency is BRL
34.08
0.00 (0.00%)
At close: Feb 5, 2026

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2013FY 2012
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '13 Dec '12
INGREZZA Revenue
2.47B2.31B1.84B
INGREZZA Revenue Growth
6.82%26.01%28.59%
ONGENTYS and Other Product Revenue
19.70M17.10M24.60M
ONGENTYS and Other Product Revenue Growth
15.20%-30.49%87.79%
Total Net Product Revenue
2.66B2.33B1.86B
Total Net Product Revenue Growth
14.00%25.26%29.13%
Royalties Revenue
23.30M18.60M21.20M
Royalties Revenue Growth
25.27%-12.26%-4.93%
Collaboration and Other Revenue
2.60M6.10M5.30M
Collaboration and Other Revenue Growth
-57.38%15.09%-3.64%
Total Collaboration Revenue
25.90M24.70M26.50M
Total Collaboration Revenue Growth
4.86%-6.79%-44.56%
Revenue (Total)
2.68B2.36B1.89B
Revenue (Total) Growth
13.90%24.81%26.76%
Updated Sep 30, 2025. Data Source: Fiscal.ai.